common.study.topics.clinical

Cardiac Sarcoidosis Randomized Trial

common.study.values.description

Cardiac Sarcoidosis Randomized Trial

Prospective randomized controlled trial comparing low dose Prednisone/Methotrexate combination to standard dose Prednisone in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone/Methotrexate combination will be as effective as standard dose Prednisone, and result in significantly better quality of life and less toxicity than standard dose Prednisone.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Prednisone

Oral prednisone tablet

Drug - Methotrexate

Oral, subcutaneous, or intramuscular methotrexate

participant.views.study.view.additional

participant.views.study.view.scientific-title

Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial

common.study.values.clinical-trial-id

NCT03593759

participant.views.study.view.id

en55Wd